- Defects in the differentiation and function of bone marrow-derived dendritic cells in non-obese diabetic mice
-
Lee M, Kim AY, Kang Y
- KMID: 648127
- J Korean Med Sci.
- 2000 Apr;15(2):217-223.
- doi: 10.3346/jkms.2000.15.2.217
Due to their high immunostimulatory ability as well as the critical role they play in the maintenance of self-tolerance, dendritic cells have been implicated in the pathogenesis of autoimmune diseases.... -
- CITED
-
- Close
- SHARE
-
- Close
- Intratumoral Administration of Secondary Lymphoid Chemokine and Unmethylated Cytosine-phosphorothioate-guanine Oligodeoxynucleotide Synergistically Inhibits Tumor Growth in Vivo
-
Oh SM, Oh K, Lee DS
- KMID: 1785982
- J Korean Med Sci.
- 2011 Oct;26(10):1270-1276.
- doi: 10.3346/jkms.2011.26.10.1270
Secondary lymphoid tissue chemokine (SLC), which is expressed in T cell zones of secondary lymphoid organs, including the spleen and lymph nodes, strongly recruits both T lymphocytes and mature dendritic... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence of Foxp3 Positive T Regulatory Cells is Increased during Progression of Cutaneous Squamous Tumors
-
Jang TJ
- KMID: 1782942
- Yonsei Med J.
- 2008 Dec;49(6):942-948.
- doi: 10.3349/ymj.2008.49.6.942
PURPOSE: Forkhead box p3 (Foxp3) positive T regulatory cells (Tregs) have a functionally immunosuppressive property that prevents effector cells from acting against self in autoimmune diseases or a tumor. It... -
- CITED
-
- Close
- SHARE
-
- Close
- Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination
-
Kim A, Noh YW, Kim KD, Jang YS, Choe YK, Lim JS
- KMID: 1123764
- Exp Mol Med.
- 2004 Oct;36(5):428-443.
Immunization with dendritic cells (DCs) pulsed with tumor antigen can activate tumor-specific cytotoxic T lymphocytes (CTL), which is responsible for tumor protection and regression. In this study, we examined whether... -
- CITED
-
- Close
- SHARE
-
- Close
- Trp-Lys-Tyr-Met-Val-Met stimulates phagocytosis via phospho-lipase D-dependent signaling in mouse dendritic cells
-
Lee HY, Kang HK, Jo EJ, Kim JI, Lee YN, Lee SH, Park YM, Ryu SH, Kwak JY, Bae YS
- KMID: 1380208
- Exp Mol Med.
- 2004 Apr;36(2):135-144.
Dendritic cells (DCs) play a key role in activating the immune response against invading pathogens as well as dying cells or tumors. Although the immune response can be initiated by... -
- CITED
-
- Close
- SHARE
-
- Close
- Anti-tumor immunostimulatory effect of heat-killed tumor cells
-
Yoon TJ, Kim JY, Kim H, Hong C, Lee H, Lee CK, Lee KH, Hong S, Park SH
- KMID: 1103596
- Exp Mol Med.
- 2008 Feb;40(1):130-144.
- doi: 10.3858/emm.2008.40.1.130
As a part of our ongoing search for a safe and efficient anti-tumor vaccine, we attempted to determine whether the molecular nature of certain tumor antigens would influence immune responses... -
- CITED
-
- Close
- SHARE
-
- Close
- In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer
-
Lee HJ, Hong CY, Kim MH, Lee YK, Nguyen-Pham TN, Park BC, Yang DH, Chung IJ, Kim HJ, Lee JJ
- KMID: 1120143
- Exp Mol Med.
- 2012 Jan;44(1):60-67.
- doi: 10.3858/emm.2012.44.1.006
Anterior gradient-2 (AGR2) promotes tumor growth, cell migration, and cellular transformation, and is one of the specific mRNA markers for circulating tumor cells in patients with gastrointestinal cancer. We investigated... -
- CITED
-
- Close
- SHARE
-
- Close
- Introduction of the CIITA gene into tumor cells produces exosomes with enhanced anti-tumor effects
-
Lee YS, Kim SH, Cho JA, Kim CW
- KMID: 1009967
- Exp Mol Med.
- 2011 May;43(5):281-290.
- doi: 10.3858/emm.2011.43.5.029
Exosomes are small membrane vesicles secreted from various types of cells. Tumor-derived exosomes contain MHC class I molecules and tumor-specific antigens, receiving attention as a potential cancer vaccine. For induction... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
-
Lee SJ, Yang A, Wu TC, Hung CF
- KMID: 2374253
- J Gynecol Oncol.
- 2016 Sep;27(5):e51.
- doi: 10.3802/jgo.2016.27.e51
Cervical cancer is the fourth most lethal women's cancer worldwide. Current treatments against cervical cancer include surgery, radiotherapy, chemotherapy, and anti-angiogenic agents. However, despite the various treatments utilized for the... -
- CITED
-
- Close
- SHARE
-
- Close
